Our team presented the primary endpoint results of the STROCARE trial at #ESOC2025. Findings showed comparable physical QoL (PROMIS-10) at 12 and 24 months between control and intervention groups. Great to see our work featured on the big stage! 🧠#StrokeResearch #STROCARE #QoL #RCT
May 21, 2025 at 11:17 AM
Presented at #ESOC2025
The StroCare trial reports no change in self-assessed quality of life, but shows positive impact on functional outcome.
CSIs Dr Rafael Bourry (@rbourry.bsky.social) breaks down the findings, watch the @VJNeurology.bsky.social interview here:
www.vjneurology.com/video/skcgce...
The StroCare trial reports no change in self-assessed quality of life, but shows positive impact on functional outcome.
CSIs Dr Rafael Bourry (@rbourry.bsky.social) breaks down the findings, watch the @VJNeurology.bsky.social interview here:
www.vjneurology.com/video/skcgce...
Final results from the StroCare study investigating a post-stroke care program
Rafael Bourry, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses findings from the StroCare study (NCT04159324), an interventional study investigating...
www.vjneurology.com
May 22, 2025 at 8:19 AM
Presented at #ESOC2025
The StroCare trial reports no change in self-assessed quality of life, but shows positive impact on functional outcome.
CSIs Dr Rafael Bourry (@rbourry.bsky.social) breaks down the findings, watch the @VJNeurology.bsky.social interview here:
www.vjneurology.com/video/skcgce...
The StroCare trial reports no change in self-assessed quality of life, but shows positive impact on functional outcome.
CSIs Dr Rafael Bourry (@rbourry.bsky.social) breaks down the findings, watch the @VJNeurology.bsky.social interview here:
www.vjneurology.com/video/skcgce...